GRAL

GRAIL, Inc. operates within the healthcare sector, specifically in the diagnostics and research industry. The company has a significant market presence with a market capitalization of $3.73 billion and annual revenues of $141.83 million. GRAIL employs approximately 1,000 people. The company's financial health is marked by substantial losses, with net income totaling -$406.24 million in the trailing twelve months. This is accompanied by negative EBITDA and free cash flow figures of -$349.38 million and -$59.18 million, respectively. The balance sheet shows a significant amount of cash, $540.13 million, while debt stands at $58.59 million. GRAIL's profitability metrics are also negative, with gross margin, operating margin, and profit margin rates of -47.5%, -346.2%, and -286.4%, respectively. GRAIL's valuation is characterized by a forward P/E ratio of -8.78 and a price to book ratio of 1.55. The company has reported revenue growth of 26.3% year-over-year, but earnings growth figures are not available.